Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ASEP Medical Holdings's Enterprise Value is €2.61 Mil.
ASEP Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.63 Mil. Therefore, ASEP Medical Holdings's EV-to-FCF for today is -4.14.
The historical rank and industry rank for ASEP Medical Holdings's EV-to-FCF or its related term are showing as below:
FRA:JJ80'
s EV-to-FCF Range Over the Past 10 Years
Min: -37.76 Med: -10.95 Max: -3.51
Current: -4.12
During the past 5 years, the highest EV-to-FCF of ASEP Medical Holdings was -3.51. The lowest was -37.76. And the median was -10.95.
FRA:JJ80's EV-to-FCF is ranked worse than 100% of 340
companies
in the Biotechnology industry
Industry Median: 14.79
vs FRA:JJ80: -4.12
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ASEP Medical Holdings (FRA:JJ80) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ASEP Medical Holdings's PE Ratio (TTM) for today is calculated as:
ASEP Medical Holdings's share price for today is €0.155.
ASEP Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.262.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:JJ80 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, ASEP Medical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's EV-to-FCF falls into.
ASEP Medical Holdings's current Enterprise Value is €2.61 Mil.
ASEP Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (FRA:JJ80) has a EV-to-FCF of -4.14 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #999999 out of 340 companies in the Biotechnology industry.
Is ASEP Medical Holdings' EV-to-FCF too high?
ASEP Medical Holdings' current EV-to-FCF is -4.14. Based on the distribution chart, ASEP Medical Holdings ranks #999999 out of 340 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #999999 out of 340 companies for EV-to-FCF. This places ASEP Medical Holdings in the lower half of its industry. The industry median EV-to-FCF is 14.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.79, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ASEP Medical Holdings and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASEP Medical Holdings's current EV-to-FCF is -4.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (FRA:JJ80) has a current EV-to-FCF of -4.14. The current EV-to-FCF is -4.14. ASEP Medical Holdings' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ASEP Medical Holdings (FRA:JJ80), the current EV-to-FCF is -4.14 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
31GF Score
Get the complete analysis for FRA:JJ80
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JJ80 has been successfully added to your 
